The Cannabinoid Δ(9)-tetrahydrocannabivarin (THCV) Ameliorates Insulin Sensitivity In Two Mouse Models Of Obesity

Diabetes Mellitus

Key Findings

THCV is a new potential treatment against obesity-associated glucose intolerance with pharmacology different from that of CB1 inverse agonists/antagonists.

Information and Links


Link: The Cannabinoid Δ(9)-tetrahydrocannabivarin (THCV) Ameliorates Insulin Sensitivity In Two Mouse Models Of Obesity

Year: 2013

DOI: 10.1038/nutd.2013.9


Ratings

(How Ratings Work)

Diabetes Mellitus — 2


Possible to probable range of efficacy of cannabis for treatment of Diabetes Mellitus according to the results found in this study.

Drugs Used

Δ(9)-Tetrahydrocannabivarin (THCV) is a neutral CB1 antagonist

AM251 (potent CB1 antagonist)